LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Article ; Online: Embryo mortality in Isg15-/- mice is exacerbated by environmental stress.

    Henkes, Luiz E / Pru, James K / Ashley, Ryan L / Anthony, Russell V / Veeramachaneni, D N Rao / Gates, Katherine C / Hansen, Thomas R

    Biology of reproduction

    2015  Volume 92, Issue 2, Page(s) 36

    Abstract: The interferon-stimulated gene 15 (Isg15) encodes a ubiquitin-like protein that is induced in the endometrium by pregnancy in mice, humans, and ruminants. Because ISG15 is a component of the innate immune system, we hypothesized that development of the ... ...

    Abstract The interferon-stimulated gene 15 (Isg15) encodes a ubiquitin-like protein that is induced in the endometrium by pregnancy in mice, humans, and ruminants. Because ISG15 is a component of the innate immune system, we hypothesized that development of the embryo, fetus, and postnatal pup may be impaired in mice lacking Isg15 (Isg15(-/-)) and that this development would be further impaired in response to environmental insults such as hypoxia. The number of implantation sites, resorption sites, dead embryos, and the changes in overall gross morphology of the uterus were evaluated in Isg15(-/-) mice on Days 7.5 and 12.5 postcoitum (dpc). Postnatal development also was monitored from birth to 12 wk of age. On 7.5 dpc, the number of implantation sites and serum progesterone concentrations were similar. However, embryo mortality increased (P < 0.05) in Isg15(-/-) dams by 12.5 dpc, resulting in smaller litter sizes (4.26 ± 0.21 embryos; n = 83 litters) compared to Isg15(+/+) females (7.78 ± 0.29 pups; n = 47 litters). Embryo mortality in Isg15(-/-) mice was further exacerbated to 70% when dams were stressed through housing under hypoxic conditions (PB = 445 mmHg; 6.5-12.5 dpc). Transmission electron microscopy revealed lesions in antimesometrial decidua as well as trophoblast cells adjacent to decidual cells on 7.5 dpc. ISG15 was localized to mesometrial decidua on 7.5 dpc. By 12.5 dpc, ISG15 was intensely localized to the labyrinth of the placenta. By 7.5 dpc, uterine natural killer cell migration into the mesometrial pole was diminished by 65% and was less prevalent in Isg15(-/-) compared to Isg15(+/+) deciduum. Postnatal growth rate of offspring that survived to birth from Isg15(-/-) and Isg15(+/+) dams was not different. Embryo mortality occurs in pregnant Isg15(-/-) mice, is exacerbated by environmental insults like maternal hypoxia, and might result from impaired early decidualization, vascular development, and formation of the labyrinth.
    MeSH term(s) Animals ; Cytokines/genetics ; Cytokines/metabolism ; Embryo Implantation/physiology ; Female ; Fetal Death ; Hypoxia/metabolism ; Mice ; Mice, Knockout ; Placenta/metabolism ; Pregnancy ; Stress, Physiological/physiology ; Ubiquitins/genetics ; Ubiquitins/metabolism ; Uterus/metabolism
    Chemical Substances Cytokines ; G1p2 protein, mouse ; Ubiquitins
    Language English
    Publishing date 2015-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1118-6
    ISSN 1529-7268 ; 0006-3363
    ISSN (online) 1529-7268
    ISSN 0006-3363
    DOI 10.1095/biolreprod.114.122002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Oxytocin and arginine vasopressin receptor evolution: implications for adaptive novelties in placental mammals.

    Paré, Pamela / Paixão-Côrtes, Vanessa R / Tovo-Rodrigues, Luciana / Vargas-Pinilla, Pedro / Viscardi, Lucas Henriques / Salzano, Francisco Mauro / Henkes, Luiz E / Bortolini, Maria Catira

    Genetics and molecular biology

    2016  Volume 39, Issue 4, Page(s) 646–657

    Abstract: Oxytocin receptor (OXTR) and arginine vasopressin receptors (AVPR1a, AVPR1b, and AVPR2) are paralogous genes that emerged through duplication events; along the evolutionary timeline, owing to speciation, numerous orthologues emerged as well. In order to ... ...

    Abstract Oxytocin receptor (OXTR) and arginine vasopressin receptors (AVPR1a, AVPR1b, and AVPR2) are paralogous genes that emerged through duplication events; along the evolutionary timeline, owing to speciation, numerous orthologues emerged as well. In order to elucidate the evolutionary forces that shaped these four genes in placental mammals and to reveal specific aspects of their protein structures, 35 species were selected. Specifically, we investigated their molecular evolutionary history and intrinsic protein disorder content, and identified the presence of short linear interaction motifs. OXTR seems to be under evolutionary constraint in placental mammals, whereas AVPR1a, AVPR1b, and AVPR2 exhibit higher evolutionary rates, suggesting that they have been under relaxed or experienced positive selection. In addition, we describe here, for the first time, that the OXTR, AVPR1a, AVPR1b, and AVPR2 mammalian orthologues preserve their disorder content, while this condition varies among the paralogues. Finally, our results reveal the presence of short linear interaction motifs, indicating possible functional adaptations related to physiological and/or behavioral taxa-specific traits.
    Language English
    Publishing date 2016-08-08
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 1445712-x
    ISSN 1678-4685 ; 1415-4757
    ISSN (online) 1678-4685
    ISSN 1415-4757
    DOI 10.1590/1678-4685-GMB-2015-0323
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Deletion of the Isg15 gene results in up-regulation of decidual cell survival genes and down-regulation of adhesion genes: implication for regulation by IL-1beta.

    Ashley, Ryan L / Henkes, Luiz E / Bouma, Gerrit J / Pru, James K / Hansen, Thomas R

    Endocrinology

    2010  Volume 151, Issue 9, Page(s) 4527–4536

    Abstract: The ubiquitin homolog interferon stimulated gene 15 (ISG15) is up-regulated in the endometrium in response to pregnancy in primates, ruminants, pigs, and mice. ISG15 covalently attaches to intracellular proteins (isgylation) and regulates numerous ... ...

    Abstract The ubiquitin homolog interferon stimulated gene 15 (ISG15) is up-regulated in the endometrium in response to pregnancy in primates, ruminants, pigs, and mice. ISG15 covalently attaches to intracellular proteins (isgylation) and regulates numerous intracellular responses. We hypothesized that ISG15 depletion (Isg15(-/-)) alters decidual tissue gene expression and that IL-1beta induces ISG15 expression and isgylation in cultured murine decidual explants and human uterine fibroblasts (HuFs). After studying the reproductive phenotype, contrary to earlier reports, up to 50% of the fetuses die between 7.5 and 12.5 d post coitum (dpc) in Isg15(-/-) mothers when mated to Isg15(-/-) fathers. Using microarray analysis, over 500 genes are differentially regulated in 7.5 dpc deciduas from Isg15(-/-) compared with Isg15(+/+) mice. The gene for interferon-inducible protein 202b, which functions in cell-survival mechanisms, was up-regulated (mRNA and protein) in deciduas from Isg15(-/-) mice. Culture of Isg15(+/+) mouse decidual explants (7.5 dpc) with IL-1beta decreased Isg15 mRNA but increased free and conjugated ISG15. In predecidual HuF cells, IL-1beta treatment increased ISG15 mRNA and isgylation. Additionally, IL-1beta up-regulated expression of enzymes (HERC5, UBCH8) that coordinate the covalent conjugation of ISG15 to target proteins, as well as the gene that encodes the deisglyation enzyme UBP43 in HuF cells. In conclusion, deletion of Isg15 gene results in 50% fetal loss after 7.5 dpc, which can be explained through differential decidual gene expression that is functionally tied to cell survival and adhesion pathways. This fetal death also might relate to impaired IL-1beta signaling, because ISG15 and isgylation are induced by IL-1beta in human and murine endometrial stromal cells.
    MeSH term(s) Animals ; Cell Adhesion/genetics ; Cell Survival/genetics ; Cells, Cultured ; Cytokines/genetics ; Cytokines/metabolism ; Decidua/cytology ; Decidua/metabolism ; Down-Regulation ; Female ; Fibroblasts/cytology ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Gene Expression/drug effects ; Gene Expression Profiling ; Gene Expression Regulation, Developmental ; Humans ; Interleukin-1beta/pharmacology ; Male ; Mice ; Mice, Knockout ; Oligonucleotide Array Sequence Analysis ; Pregnancy ; Reverse Transcriptase Polymerase Chain Reaction ; Time Factors ; Tissue Culture Techniques ; Ubiquitins/genetics ; Ubiquitins/metabolism ; Up-Regulation ; Uterus/cytology
    Chemical Substances Cytokines ; G1p2 protein, mouse ; Interleukin-1beta ; Ubiquitins ; ISG15 protein, human (60267-61-0)
    Language English
    Publishing date 2010-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/en.2010-0166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression.

    Henkes, Luiz E / Davis, John S / Rueda, Bo R

    Reproductive biology and endocrinology : RB&E

    2003  Volume 1, Page(s) 87

    Abstract: The corpus luteum is a unique organ, which is transitory in nature. The development, maintenance and regression of the corpus luteum are regulated by endocrine, paracrine and autocrine signaling events. Defining the specific mediators of luteal ... ...

    Abstract The corpus luteum is a unique organ, which is transitory in nature. The development, maintenance and regression of the corpus luteum are regulated by endocrine, paracrine and autocrine signaling events. Defining the specific mediators of luteal development, maintenance and regression has been difficult and often perplexing due to the complexity that stems from the variety of cell types that make up the luteal tissue. Moreover, some regulators may serve dual functions as a luteotropic and luteolytic agent depending on the temporal and spatial environment in which they are expressed. As a result, some confusion is present in the interpretation of in vitro and in vivo studies. More recently investigators have utilized mutant mouse models to define the functional significance of specific gene products. The goal of this mini-review is to identify and discuss mutant mouse models that have luteal anomalies, which may provide some clues as to the significance of specific regulators of corpus luteum function.
    MeSH term(s) Animals ; Corpus Luteum/abnormalities ; Corpus Luteum/embryology ; Corpus Luteum/growth & development ; Corpus Luteum/physiology ; Disease Models, Animal ; Female ; Mice ; Mutation/genetics
    Language English
    Publishing date 2003-11-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ISSN 1477-7827
    ISSN (online) 1477-7827
    DOI 10.1186/1477-7827-1-87
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cytokeratin 18 expression inhibits cytokine-induced death of cervical cancer cells.

    Sullivan, Brian T / Cherry, Jessica A / Sakamoto, Hideo / Henkes, Luiz E / Townson, David H / Rueda, Bo R

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

    2010  Volume 20, Issue 9, Page(s) 1474–1481

    Abstract: Objectives: In cervical cancer, increased cytokeratin 18 (CK18) filament expression is associated with disease progression. However, it may also provide resistance to cytokine-induced apoptosis. The present study tested whether CK18 expression ... ...

    Abstract Objectives: In cervical cancer, increased cytokeratin 18 (CK18) filament expression is associated with disease progression. However, it may also provide resistance to cytokine-induced apoptosis. The present study tested whether CK18 expression influences susceptibility to cytokine-induced apoptosis.
    Methods: The cervical cancer cell lines C-4II (high CK18 expression), ME-180 (low CK18 expression), and 2 subtypes of HeLa cells containing or lacking CK18 expression (CK18+ and CK18- cells, respectively) were exposed to vehicle (control), Fas ligand (FasL) (50 ng/mL), or tumor necrosis factor α (TNF-α; 10 ng/mL) without/with cycloheximide (CHX; 2.5 μg/mL) to test the hypothesis that diminished CK18 expression increases susceptibility to cytokine-induced apoptosis.
    Results: Flow cytometric analysis of cell death via TUNEL staining revealed that cytokine-induced apoptosis was 2-fold greater in ME-180 cells than C-4II cells in response to FasL+CHX or TNF-α+CHX (P < 0.05). Similarly, there was a higher incidence of FasL-induced apoptosis in CK18- HeLa cells (23% and 91% apoptotic for FasL and FasL+CHX, respectively) than CK18+ HeLa cells (1% and 11%, respectively; P < 0.05). Surprisingly, TNF-α had no effect on either CK18+ or CK18- HeLa cells (P > 0.05). Caspase 3 activity was greater in CK18- HeLa cells than in CK18+ HeLa cells at 8 and 18 hours after FasL treatment (P < 0.05), an effect abrogated by the caspase 8 inhibitor IETD-fmk (P < 0.05).
    Conclusions: Cervical cancer cells with diminished CK18 expression are more susceptible to cytokine-induced apoptosis, particularly in response to FasL treatment. These observations suggest that relative CK18 expression is an important factor when considering therapeutic strategies to enhance immune cell-mediated death of cervical cancer cells.
    MeSH term(s) Apoptosis/drug effects ; Apoptosis/physiology ; Carcinoma/genetics ; Carcinoma/metabolism ; Carcinoma/pathology ; Caspase 3/metabolism ; Cell Death/drug effects ; Cell Death/genetics ; Cytokines/administration & dosage ; Cytokines/pharmacology ; Down-Regulation/drug effects ; Down-Regulation/genetics ; Drug Evaluation, Preclinical ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Fas Ligand Protein/administration & dosage ; Fas Ligand Protein/pharmacology ; Female ; HeLa Cells ; Humans ; Keratin-18/antagonists & inhibitors ; Keratin-18/genetics ; Keratin-18/metabolism ; Keratin-18/physiology ; RNA, Small Interfering/administration & dosage ; RNA, Small Interfering/pharmacology ; Tumor Cells, Cultured ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology
    Chemical Substances Cytokines ; Fas Ligand Protein ; Keratin-18 ; RNA, Small Interfering ; Caspase 3 (EC 3.4.22.-)
    Language English
    Publishing date 2010-10-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1070385-8
    ISSN 1525-1438 ; 1048-891X
    ISSN (online) 1525-1438
    ISSN 1048-891X
    DOI 10.1111/IGC.0b013e3181fc3a03
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The involvement of proline-rich 15 in early conceptus development in sheep.

    Purcell, Scott H / Cantlon, Jeremy D / Wright, Casey D / Henkes, Luiz E / Seidel, George E / Anthony, Russell V

    Biology of reproduction

    2009  Volume 81, Issue 6, Page(s) 1112–1121

    Abstract: The ruminant conceptus undergoes a period of elongation that is required for maternal recognition of pregnancy, prior to attaching to the endometrium. The purpose of these studies was to investigate the role of proline-rich 15 (PRR15) in the sheep ... ...

    Abstract The ruminant conceptus undergoes a period of elongation that is required for maternal recognition of pregnancy, prior to attaching to the endometrium. The purpose of these studies was to investigate the role of proline-rich 15 (PRR15) in the sheep conceptus by examining mRNA expression, protein localization, and the effect of PRR15 mRNA degradation. Conceptuses were collected on Days 11, 13, 15, 16, 17, 21, and 30 after mating. Quantitative RT-PCR showed expression of PRR15 mRNA corresponded with the process of trophoblast elongation, with peak expression occurring on Days 15 and 16. A recombinant ovine PRR15 was generated and used to create polyclonal antibodies against PRR15. Immunohistochemistry of a Day 15 conceptus indicated that PRR15 was localized predominantly in the nucleus of the trophectoderm and extraembryonic primitive endoderm. To test whether PRR15 was required during early conceptus development, RNA interference was employed. Blastocysts collected on Day 8 after mating were infected with a lentivirus expressing a short-hairpin RNA (shRNA) that targeted PRR15 mRNA for degradation, an shRNA containing a three-nucleotide mismatch to PRR15 mRNA, or a lentivirus expressing no shRNA. After infection, blastocysts were transferred into recipient ewes and collected back on Day 15 of gestation. Although the majority of the control and mismatched shRNA-treated conceptuses elongated and survived to Day 15, none of the embryos treated with the lentivirus expressing shRNA against PRR15 mRNA elongated, and most died. In conclusion, expression of PRR15 mRNA occurred during a narrow window of conceptus development, and degradation of PRR15 mRNA led to conceptus demise or abnormal development.
    MeSH term(s) Animals ; Blastocyst/metabolism ; Embryo Implantation/genetics ; Embryo Implantation/physiology ; Embryo Transfer ; Embryo, Mammalian/metabolism ; Embryonic Development/genetics ; Embryonic Development/physiology ; Endometrium/metabolism ; Female ; Gene Expression Regulation, Developmental/genetics ; Gene Expression Regulation, Developmental/physiology ; Genes/genetics ; Genes/physiology ; Gestational Age ; Immunohistochemistry ; Interferon Type I/genetics ; Interferon Type I/metabolism ; Microscopy, Fluorescence ; Placenta/metabolism ; Pregnancy ; Pregnancy Proteins/genetics ; Pregnancy Proteins/metabolism ; Pregnancy, Animal ; Proline/genetics ; RNA Interference ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Sheep/physiology ; Trophoblasts/metabolism
    Chemical Substances Interferon Type I ; Pregnancy Proteins ; RNA, Messenger ; interferon tau ; Proline (9DLQ4CIU6V)
    Language English
    Publishing date 2009-07-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1118-6
    ISSN 1529-7268 ; 0006-3363
    ISSN (online) 1529-7268
    ISSN 0006-3363
    DOI 10.1095/biolreprod.109.076190
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Endocrine delivery of interferon tau protects the corpus luteum from prostaglandin F2 alpha-induced luteolysis in ewes.

    Antoniazzi, Alfredo Q / Webb, Brett T / Romero, Jared J / Ashley, Ryan L / Smirnova, Natalia P / Henkes, Luiz E / Bott, Rebecca C / Oliveira, João F / Niswender, Gordon D / Bazer, Fuller W / Hansen, Thomas R

    Biology of reproduction

    2013  Volume 88, Issue 6, Page(s) 144

    Abstract: ... stimulated gene (i.e., ISG15) mRNA. Infusion of 200 μg of IFNT over 24 h induced greater mRNA concentrations ...

    Abstract Paracrine release of ovine interferon tau (oIFNT) from the conceptus alters release of endometrial prostaglandin F2 alpha (PGF) and prevents luteolysis. Endocrine release of oIFNT into the uterine vein occurs by Day 15 of pregnancy and may impart resistance of the corpus luteum (CL) to PGF. It was hypothesized that infusion of recombinant oIFNT (roIFNT) into the uterine or jugular veins on Day 10 of the estrous cycle would protect the CL against exogenous PGF-induced luteolysis. Osmotic pumps were surgically installed in 24 ewes to deliver bovine serum albumin (BSA; n = 12) or roIFNT (200 μg/day; n = 12) for 24 h into the uterine vein. Six ewes in each treatment group received a single injection of PGF (4 mg/58 kg body weight) 12 h after pump installation. In a second experiment, BSA or roIFNT was delivered at 20 or 200 μg/day into the uterine vein or 200 μg/day into the jugular vein for 72 h in 30 ewes. One half of these ewes received an injection of PGF 24 h after pump installation. Concentrations of progesterone in serum declined in BSA-treated ewes injected with PGF, but were sustained in all ewes infused with 20 μg/day of roIFNT into the uterine vein and 200 μg of roIFNT into the jugular vein followed 24 h later with injection of PGF. All concentrations of roIFNT and modes of delivery (uterine or jugular vein) increased luteal concentrations of IFN-stimulated gene (i.e., ISG15) mRNA. Infusion of 200 μg of IFNT over 24 h induced greater mRNA concentrations for cell survival genes, such as BCL2-like 1 (BCL2L1 or Bcl-xL), serine/threonine kinase (AKT), and X-linked inhibitor of apoptosis (XIAP) and decreased prostaglandin F receptor (PTGFR) mRNA concentrations, when compared to controls. It is concluded that endocrine delivery of roIFNT, regardless of route (uterine or jugular vein), effectively protects CL from the luteolytic actions of PGF by mechanisms that involve ISGs and stabilization of cell survival genes.
    MeSH term(s) Animals ; Corpus Luteum/drug effects ; Corpus Luteum/metabolism ; Dinoprost/pharmacology ; Endometrium/blood supply ; Endometrium/drug effects ; Endometrium/metabolism ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Estrous Cycle/drug effects ; Estrous Cycle/metabolism ; Female ; Interferon Type I/pharmacology ; Luteolysis/drug effects ; Luteolysis/metabolism ; Organic Anion Transporters/genetics ; Organic Anion Transporters/metabolism ; Pregnancy Proteins/pharmacology ; Progesterone/blood ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Receptors, Oxytocin/genetics ; Receptors, Oxytocin/metabolism ; Receptors, Prostaglandin/genetics ; Receptors, Prostaglandin/metabolism ; Sheep ; Uterus/blood supply ; Uterus/drug effects ; Uterus/metabolism
    Chemical Substances Estrogen Receptor alpha ; Interferon Type I ; Organic Anion Transporters ; Pregnancy Proteins ; RNA, Messenger ; Receptors, Oxytocin ; Receptors, Prostaglandin ; interferon tau ; Progesterone (4G7DS2Q64Y) ; Dinoprost (B7IN85G1HY)
    Language English
    Publishing date 2013-06-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1118-6
    ISSN 1529-7268 ; 0006-3363
    ISSN (online) 1529-7268
    ISSN 0006-3363
    DOI 10.1095/biolreprod.112.105684
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression

    Rueda Bo R / Davis John S / Henkes Luiz E

    Reproductive Biology and Endocrinology, Vol 1, Iss 1, p

    2003  Volume 87

    Abstract: Abstract The corpus luteum is a unique organ, which is transitory in nature. The development, maintenance and regression of the corpus luteum are regulated by endocrine, paracrine and autocrine signaling events. Defining the specific mediators of luteal ... ...

    Abstract Abstract The corpus luteum is a unique organ, which is transitory in nature. The development, maintenance and regression of the corpus luteum are regulated by endocrine, paracrine and autocrine signaling events. Defining the specific mediators of luteal development, maintenance and regression has been difficult and often perplexing due to the complexity that stems from the variety of cell types that make up the luteal tissue. Moreover, some regulators may serve dual functions as a luteotropic and luteolytic agent depending on the temporal and spatial environment in which they are expressed. As a result, some confusion is present in the interpretation of in vitro and in vivo studies. More recently investigators have utilized mutant mouse models to define the functional significance of specific gene products. The goal of this mini-review is to identify and discuss mutant mouse models that have luteal anomalies, which may provide some clues as to the significance of specific regulators of corpus luteum function.
    Keywords Physiology ; QP1-981 ; Science ; Q ; DOAJ:Physiology ; DOAJ:Biology ; DOAJ:Biology and Life Sciences
    Subject code 501
    Language English
    Publishing date 2003-11-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo.

    Henkes, Luiz E / Sullivan, Brian T / Lynch, Maureen P / Kolesnick, Richard / Arsenault, Danielle / Puder, Mark / Davis, John S / Rueda, Bo R

    Proceedings of the National Academy of Sciences of the United States of America

    2008  Volume 105, Issue 22, Page(s) 7670–7675

    Abstract: TNF is well known for its role in inflammation, including direct effects on the vasculature. TNF also is implicated in the regulation of reproduction by its actions to affect ovarian steroidogenic cells and to induce apoptosis of corpus luteum (CL)- ... ...

    Abstract TNF is well known for its role in inflammation, including direct effects on the vasculature. TNF also is implicated in the regulation of reproduction by its actions to affect ovarian steroidogenic cells and to induce apoptosis of corpus luteum (CL)-derived endothelial cells in vitro. We hypothesized that the disruption of TNF signaling would postpone the regression of the highly vascularized CL in vivo, and this effect could be replicated in mutant mouse models lacking TNF receptor (TNFRI(-/-)) and/or a critical enzyme of TNF signaling, acid sphingomyelinase (ASMase(-/-)). In the current study, the treatment of pseudopregnant mice with the luteolytic mediator prostaglandin F2-alpha (PGF) significantly increased TNF in the ovaries when compared with saline-treated controls. Treatment with PGF also reduced serum progesterone (P4) concentrations and caused involution of the CL. However, pretreatment of pseudopregnant mice with Etanercept (ETA), a TNF-neutralizing antibody, inhibited the PGF-induced decrease in P4 and delayed luteal regression. A similar outcome was evident in pseudopregnant TNFRI(-/-) animals. Treatment of luteal microvascular endothelial cells (MVECs) with TNF provoked a significant increase in ASMase activity when compared with the corresponding controls. Furthermore, TNF-induced MVEC death was inhibited in the ASMase(-/-) mice. The ASMase(-/-) mice displayed no obvious evidence of luteal regression 24 h after treatment with PGF and were resistant to the PGF-induced decrease in P4. Together these data provide evidence that TNF plays an active role in luteolysis. Further studies are required to determine the deleterious effects of anti-inflammatory agents on basic ovarian processes.
    MeSH term(s) Animals ; Apoptosis ; Capillaries/cytology ; Capillaries/drug effects ; Capillaries/metabolism ; Ceramides/metabolism ; Corpus Luteum/cytology ; Corpus Luteum/metabolism ; Corpus Luteum/physiology ; Dinoprost/pharmacology ; Endothelium, Vascular/cytology ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Etanercept ; Female ; Immunoglobulin G/pharmacology ; Luteolysis/drug effects ; Luteolysis/genetics ; Luteolysis/metabolism ; Mice ; Mice, Knockout ; Progesterone/blood ; Progesterone/metabolism ; Receptors, Tumor Necrosis Factor ; Receptors, Tumor Necrosis Factor, Type I/antagonists & inhibitors ; Receptors, Tumor Necrosis Factor, Type I/genetics ; Sphingomyelin Phosphodiesterase/genetics ; Sphingomyelin Phosphodiesterase/metabolism ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/metabolism ; Tumor Necrosis Factor-alpha/pharmacology
    Chemical Substances Ceramides ; Immunoglobulin G ; Receptors, Tumor Necrosis Factor ; Receptors, Tumor Necrosis Factor, Type I ; Tnfrsf1a protein, mouse ; Tumor Necrosis Factor-alpha ; Progesterone (4G7DS2Q64Y) ; Dinoprost (B7IN85G1HY) ; acid sphingomyelinase-1 (EC 3.1.4.-) ; Sphingomyelin Phosphodiesterase (EC 3.1.4.12) ; Etanercept (OP401G7OJC)
    Language English
    Publishing date 2008-05-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.0712260105
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Ubp43 gene expression is required for normal Isg15 expression and fetal development.

    Rempel, Lea A / Austin, Kathleen J / Ritchie, Kenneth J / Yan, Ming / Shen, Meifeng / Zhang, Dong-Er / Henkes, Luiz E / Hansen, Thomas R

    Reproductive biology and endocrinology : RB&E

    2007  Volume 5, Page(s) 13

    Abstract: Background: Isg15 covalently modifies murine endometrial proteins in response to early pregnancy. Isg15 can also be severed from targeted proteins by a specific protease called Ubp43 (Usp18). Mice lacking Ubp43 (null) form increased conjugated Isg15 in ... ...

    Abstract Background: Isg15 covalently modifies murine endometrial proteins in response to early pregnancy. Isg15 can also be severed from targeted proteins by a specific protease called Ubp43 (Usp18). Mice lacking Ubp43 (null) form increased conjugated Isg15 in response to interferon. The Isg15 system has not been examined in chorioallantoic placenta (CP) or mesometrial (MM) components of implantation sites beyond 9.5 days post coitum (dpc). It was hypothesized that deletion of Ubp43 would cause disregulation of Isg15 in implantation sites, and that this would affect pregnancy rates.
    Methods: Heterozygous (het) Ubp43 mice were mated and MM and CP implantation sites were collected on 12.5 and 17.5 days post-coitum (dpc).
    Results: Free and conjugated Isg15 were greater on 12.5 versus 17.5 dpc in MM. Free and conjugated Isg15 were also present in CP, but did not differ due to genotype on 12.5 dpc. However, null CP had greater free and conjugated Isg15 when compared to het/wt on 17.5 dpc. Null progeny died in utero with fetal genotype ratios (wt:het:null) of 2:5:1 on 12.5 and 2:2:1 on 17.5 dpc. Implantation sites were disrupted within the junctional zone and spongiotrophoblast, contained less vasculature based on lectin B4 staining and contained greater Isg15 mRNA and VEGF protein in Ubp43 null when compared to wt placenta.
    Conclusion: It is concluded that Isg15 and its conjugates are present in implantation sites during mid to late gestation and that deletion of Ubp43 causes an increase in free and conjugated Isg15 at the feto-maternal interface. Also, under mixed genetic background, deletion of Ubp43 results in fetal death.
    MeSH term(s) Animals ; Cell Hypoxia/genetics ; Cytokines/genetics ; Cytokines/metabolism ; Embryo Implantation/genetics ; Endopeptidases/genetics ; Endopeptidases/metabolism ; Female ; Fetal Development/genetics ; Gene Expression Regulation, Developmental ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Models, Biological ; Neovascularization, Physiologic/genetics ; Placenta/anatomy & histology ; Placenta/metabolism ; Pregnancy ; Pregnancy, Animal ; Ubiquitin Thiolesterase ; Ubiquitins/genetics ; Ubiquitins/metabolism
    Chemical Substances Cytokines ; G1p2 protein, mouse ; Ubiquitins ; Endopeptidases (EC 3.4.-) ; Usp18 protein, mouse (EC 3.4.19.-) ; Ubiquitin Thiolesterase (EC 3.4.19.12)
    Language English
    Publishing date 2007-03-26
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 1477-7827
    ISSN (online) 1477-7827
    DOI 10.1186/1477-7827-5-13
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top